Resistance Against Leishmania donovani Induced with an Aluminum Hydroxide Vaccine
|
|
- Spencer Lawrence
- 5 years ago
- Views:
Transcription
1 ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 18, No. 2 Copyright 1988, Institute for Clinical Science, Inc. Resistance Against Leishmania donovani Induced with an Aluminum Hydroxide Vaccine J. C. JARECKI-BLACK,* K. L. HALLMAN,* E. R. JAM ES,! Ph.D., and A. B. GLASSMAN, M.D.*$ *Department of Pathology and Laboratory Medicine, fdepartment of Ophthalmology, Medical University of South Carolina, Charleston, SC ABSTRACT Mice immunized with a subcutaneous protocol combining killed parasites and aluminum hydroxide gel exhibited significant resistance against subsequent challenge with Leishmania donovani promastigotes. Protection was greatest using 25 mg of aluminum hydroxide per injection. Resistance elicited by this killed parasite and aluminum hydroxide protocol was as effective on day 14 as that provided by immunization with a glucan and killed parasite preparation, and more effective in hepatic amastigote reduction at day 28. The effectiveness of aluminum hydroxide as an adjuvant appears to result, at least in part, from its ability to activate macrophages, thus aiding in the elimination of this intracellular parasite. Introduction Leishmania donovani is an obligate intracellular parasite which multiplies in culture or the sandfly vector as a prom astigote or flagellated form. W hen introduced into a vertebrate host, the parasite is engulfed by phagocytic cells, transforms to the amastigote stage, and disseminates throughout the reticuloendothelial system. The disease in man is often fatal, although spontaneous recovery may occur.12 Current treatment consists of chemotherapeutic intervention in the form of pentavalent antimonial compounds, but such drugs are relatively toxic and treatm ent failure som etim es occurs.17 The screening of potential new drugs21 and advances in the methods of drug delivery16 are being investigated, but vaccin e-in d u ced resistan ce w ould be a major step in the eventual control and prevention of human visceral leishmaniasis. R ecently in our laboratory, it was demonstrated that such immunoprophylaxis is feasible using formalin-killed parasites administered with glucan, a (31,3- polyglucose derivative of yeast cell walls, as an adjuvant. Protection was elicited not only by intravenous administration of the glucan-killed parasite combination4 but also with a subcutaneous immunization protocol /88/ $00.90 Institute for Clinical Science, Inc. t Present address: Senior Vice-President for Medical Affairs, M ontefiore Medical Center, 111 East 210th Street, Bronx, NY 10467
2 LEISHMANIA DONOVANI RESISTANCE BY ALUMINUM HYDROXIDE 73 Only lim ited trials with glucan have been conducted, and it is not currently approved for human use. This study was undertaken, therefore, to examine the efficacy of aluminum hydroxide gel, an adjuvant already available in commercial vaccines, in p o te n tia tin g resistance against v isceral leish m an iasis. O ur results demonstrate that such an immunization protocol can successfully elicit significant resistance against L. donovani, thus indicating that immunoprophylaxis may eventually be possible. Materials and Methods E x p e r im e n t a l M o d e l a n d P a r a s it e L eish m a n ia d o n o vani, stra in 2S (WR371), is maintained in our laboratory in axenic c u ltu re.19 G row th m edium consists of Media 199 supplemented 10 percent with lysed, defibrinated rabbit blood and 14.6 mg L-glutamine per litre. C u ltu res are in itiate d from m inced mouse spleen and passaged at four to five day intervals. Prom astigotes for immunization or challenge are harvested within 10 serial passage of culture initiation. F em ale C 57B L/6 m ice* w ere housed in air-conditioned quarters with food and water provided ad libitum. The mice were eight to 10 weeks old at the beginning of each experiment. A d ju v a n t P r e p a r a t io n Glucan (G)t and gelatinous aluminum hydroxide (AL)$ were purchased as standard formulations. The glucan consisted of a particulate suspension in dextrose at a concentration of 5 mg per ml, and alum inum hydroxide gel was suspended in Earle s Balanced Salt Solution (EBSS) at a concentration of 250 mg per ml. * Jackson Laboratories. t Accurate Chemical and Scientific Corporation. $ Fisher Scientific Company. I m m u n iz a t io n P r o t o c o l Promastigotes were harvested during stationary phase growth by centrifugation (900 g, 15 min) as a previous study has shown that stationary-phase parasites are more im m unogenic.7 The parasites were washed three times in EBSS, and killed in 0.1 percent formalin for 30 min at room tem perature. Form alin-killed parasites (P) were kept at 4 C overnight, washed three times, counted in a hemocytometer and resuspended in EBSS at a concentration of 108 per ml. Animals were immunized with adjuvant (25 mg AL or 0.5 mg G) combined with 107 parasites, adjuvant alone (AL or G), parasites alone (P), or were untreated (NT). The potentiation of resistance to L. donovani infection as a function of dosage response to alum inum hydroxide was also examined by immunizing additional groups of mice with either 25 mg, 12.5 mg, or 6.25 mg Al combined with 107 killed parasites. All animals received three isovolumetric injections subcutaneously at four day intervals (weekly for the dosage response experiment), and were challenged via the tail vein 21 days post-immunization with 107 prom astigotes per mouse. M o n it o r in g o f I n f e c t io n C o u r s e G roups of m ice w ere sacrificed in chloroform vapor 14 and 28 days postc h a llen g e. Body, sp le en an d liv e r weights were recorded and impression slides were made from liver and spleen. Slides w ere fixed in methanol, stained with Giemsa, and parasite burdens in liv e r and sp le e n w ere d e te rm in e d according to Stauber s m ethod.20 Results were analyzed by the Mann-W hitney u- test10 and were considered significant at a p < 0.05.
3 74 JARECKI-BLACK, HALLMAN, JAMES, AND GLASSMAN Results Mice immunized subeutaneously with aluminum hydroxide and killed parasites (ALP) dem onstrated significant resistance (p < 0.001) to leishmanial infection as compared to controls receiving adjuvant alone (AL), parasite alone (P), or untreated mice (table I). The administratio n of a lu m in u m h y d ro x id e alone re s u lte d in a n o n sp e c ific im m une response against L. donovani infection as evidenced by reduced parasite burdens in AL mice as com pared to untreated animals (p < 0.05), but this non-specific protection was no longer significant at day 28. The ALP group, however, still exhibited resistance against infection at day 28 post-challenge, and this protection was significant compared to all control groups (p < 0.001). Results of mice im munized with the ALP protocol, compared to mice receiving glucan and killed parasites (GP), are shown in table II. Controls were immunized subeutaneo usly w ith adjuvant alone (G or AL), killed parasites alone (P), or were untreated. At day 14 postchallenge, both the ALP and GP preparations resulted in a significant reduction T A B L E I Resistance Against LeM>kma.yu.a. donovani Elicited by an Aluminum Hydroxide and Killed Parasite Vaccine Hepatic Amastigote Burdens (X 10^) Group Day 14 Day 28 ALP *5.95 ± 0.6 *3.91 ± 0.9 AL * ± 1.9 P ± ± 2.4 NT ± ± 1.6 Mice received three subcutaneous injections at four day intervals followed by intravenous challenge (107 viable promastigotes per mouse) 21 days later. ALP: aluminum hydroxide gel (25 mg) with killed parasites (10^); AL: aluminum hydroxide alone; P: killed parasites alone; NT: untreated. Results reported as mean ± standard error; N = 7 mice per group. *p < 0.05 compared to untreated controls. TABLE I I Comparison of Vaccines Combining Killed Parasites with Aluminum Hydroxide or with Glucan Hepatic Amastigote Burdens (X 107) Group Day 14 Day 28 I Adjuvant Groups GP * ALP * * II Control Groups AL * G P NT Mice received three subcutaneous injections of adjuvant alone (G = 0.6 mg; AL = 25 mg), killed promastigotes alone (10^), killed promastigotes plus adjuvant, or were untreated. Injections were given at four day intervals prior to challenge with 107 viable promastigotes 21 days after the last immunization. AL: aluminum hydroxide gel, G: glucan, P: killed parasites, NT: untreated. Results reported as mean ± standard error; N = 7 mice per group. *p < 0.05 as compared to untreated controls. in hepatic am astigote proliferation in recipients as compared to all controls (p < 0.05). The level of resistance induced in the recipients of the two different immunization protocols was similar. By day 28 post-challenge, however, the GP group no longer dem onstrated a difference in amastigote infection as compared to untreated mice or other controls. Both the ALP (p < 0.001) and AL (p < 0.01) treatments still provided significant protection against infection at day 28, again demonstrating that the administration of alum inum hydroxide alone may elicit non-specific resistance against L. donovani. Mice immunized with 25 mg Al combined with killed parasites exhibit optimal resistance to L. donovani challenge as compared to groups receiving lesser dosages (12.5 mg or 6.25 mg) of the adjuvant (p < 0.01) as shown in table III. Mice immunized with 12.5 mg of aluminum hydroxide and killed parasites also d em o nstrated increased resistance
4 Group LEISHMANIA DONOVANI RESISTANCE BY ALUMINUM HYDROXIDE 75 T A BLE III Potentiation of Resistance Against LesiihmarUa donova.ru. as a Function of Dose Response to Aluminum Hydroxide Hepatic Parasite. Burden (X 10&) Day 30 a l 25p *18.6 ± 5.5 ALi2P *30.5 ± 7.7 AL6P 30.0 ± 9.9 P 50.7 ± 9.5 NT ± 59.1 Mice received three subcutaneous injections at weekly intervals combining killed parasites with aluminum hydroxide (25 mg, 12.5 mg or 6.25 mg respectively). Intravenous challenge (107 promastigotes per mouse) was 30 days post immunization. Results are reported as mean ± standard error; N = 7 mice per group. *p < 0.05 as compared to untreated controls. against infection; however, such resistance was not as significant as that evidenced in mice receiving the higher dosage of adjuvant (p < 0.05). H epatic amastigote burdens of mice immunized with 6.25 mg Al and killed parasites did not differ from those of untreated controls. Discussion This report demonstrates that immunization against Leishmania donovani using killed parasites and alum inum hydroxide in a subcutaneous immunization protocol may be a practical method for the prevention of visceral leishmaniasis. The feasibility of immunoprophylaxis as a method of control for leishmaniasis is not new. Im munization against Leishmania tropica with live cultures has been evaluated previously, and successful field trials of frozen stored vaccine have been undertaken in Israel.10 Cutaneous leishm aniasis still rem ains the only protozoan disease for which vaccination is practical; however, other experim e n ta l im m u n iz a tio n tria ls h av e recently met with some success. Howard et al utilized irradiated (150 Krad) L. tropica promastigotes in an intravenous protocol to induce protection against challenge in Balb/c mice, assessing protection both by healing of the lesion and survival of the mouse.5 Our laboratory has previously demonstrated protection against L. donovani challenge using a subcutaneous immunization protocol, combining the adjuvant glucan with killed promastigotes. In this and a previous study employing an intravenous protocol,4 no protection resulted from the administration of dead promastigotes alone. The present study confirms that the inclusion of an adjuvant is essential for protection to be conferred against L. donovani in our model. The experiments described herein assess the resistance resulting from the administration of a protocol combining aluminum hydroxide and killed parasites and compare the results of that subcutaneous immunization protocol to one utilizing glucan as the adjuvant. The glucan and killed parasite protocol provided significant protection to recipients at day 14 post-challenge; how ever, resistan ce against infection was no longer evident at day 28. Protection provided by the alum inum hydroxide and killed parasite protocol was significant throughout the entire time course of our study. The mechanisms responsible for the success of alum inum hydroxide as an adjuvant still remain to be identified. It is known that cellular responses to the in jectio n of antig en in alu m in a gel include granulom a form ation and the influx of effector cells such as macrophages and plasma cells.14 Antibody production probably plays a limited role in eliciting protection against visceral leishmaniasis, as it appears that cell mediated im m une m echanism s are of prim ary im portance in controlling infection,15 and in promoting vaccine-induced resistance.6 The im m une response w hich occurs when an adjuvant combined with parasite antigen is processed by macrophages ultimately augments the lympho
5 76 JARECKI-BLACK, HALLMAN, JAMES, AND GLASSMAN cytic immune response, resulting in the proliferation and differentiation of these cells. Lym phocytes activated in this m anner produce soluble factors, and the production of such factors also results in the activation of m acrophages.9 Such activated phagocytes are able to kill Leishmania amastigotes which otherwise can survive and replicate in resident macrophages.13 The present study confirms that the adm inistration of aluminum hydroxide with a killed parasite vaccine results in decreased infection in vivo. Additionally, the presentation of leishmanial antigens in the context of a killed parasite vaccine should prom ote the macrophage processing essential for enhanced immune responsiveness. A further advantage of the adjuvanticity of aluminum hydroxide is its availability and proven safety. Although limited human trials utilizing glucan have been conducted,11 it is presently not approved for other than experim ental use. A lum inum hydroxide is already available as a commercial adjuvant, and has proven to be safe when used with antigens such as tetanus and diptheria toxoids.18 Antibody responses elicited by an aluminum hydroxide-absorbed cholera vaccine have also been shown to be higher and longer lasting than those following administration of the plain vaccin e.8 In d eed, the effectiveness and safety of aluminum hydroxide as an adjuvant has not exceeded.2 It has been shown by the present authors that an im m unization protocol combining killed parasites with the adjuvant aluminum hydroxide can successfully induce resistance against L. donovani infection. For such immunoprophylaxis to be acceptable, however, immunization must be as innocuous as possible. Protection elicited by a subcutaneous immunization protocol appears to have considerable practical advantages for attainment of such a goal, and th e d em o n strated ad ju v an ticity and safety of aluminum hydroxide suggest that further evaluation of this vaccine is deserved. Acknowledgments Thanks are extended to Mrs. Emily Davidson for editorial services and to Dr. Janies Liberatos for helpful discussion. This investigation received financial support from the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. References 1. G r e e n, M. D., K a r k, J. D., W it z t u m, E., G r e en b l a t t, C. L., and Sp ir a, D. T.: Frozen stored Leishmania tropica vaccine: The effect of dose, route of administration and storage on the clinical lesion. Trans. Royal. Soc. Trop. Med. Hyg. 77: , H lllem AN, M. R.: Newer directions in vaccine d e v elo p m en t and u tiliz a tio n. J. Inf. D is. 252:407-20, H olbrook, T. W. and C oo k, J. A.: Immunization of mice against Leishmania donovani by subcutaneous injections of dead promastigotes. Amer. J. Trop. Med. H yg. 32:51-53, H o l b r o o k, T. W., C o o k, J. A., a n d Pa r k e r, B. W.: Im m unization against Leishmania donovani: glucan as an adjuvant w ith killed p ro m astigotes. Am er. J. Trop. M ed. H yg. 30: , H o w a r d, J. G., L i e w, F. Y., H a l e, C. and N ic k l in, S.: Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective im m unity against fatal Leishmania tropica infection induced by irradiated promastigotes. J. Immun. 732: , J a r e c k i-b la c k, J. C., G l a ssm a n, A. B., and J a m e s, E. R.: Adoptive transfer of vaccineinduced resistance to Leishm ania donovani. Amer. J. Trop. Med. Hyg. 34: , Ja r e c k i-b l a c k, J. C., Ja m e s, E. R., K ir s h t e in, J. W., K ir s h t e in, J. D., and G l a ssm a n, A. B.: Leishmania donovani: Im m unization against infection as a function of parasite growth phase. Amer. J. Trop. Med. Hyg. 35: , Joo, I.: Antigenicity testing of plain and aluminum hydroxide-absorbed whole-cell cholera vaccines. Acta Tropica 36: , K e n d e, M.: Role of macrophages in the expression of immune responses. J. Amer. Vet. Med. Assoc. 182: , M a n n, H. B. and W h it n ey, D. R.: On a test of whether one of two random variables is stochastically larger than the other. Ann. Math. Stat. 28:52-54, M a n s e l l, P. W. A., Ro w d e n, G., and H a m m er, G.: Clinical experience with the use of glu-
6 LEISHMANIA DONOVANI RESISTANCE BY ALUMINUM HYDROXIDE can. Immune Modulation and Control of Neoplasia by Adjuvant Therapy. Chiragos, M.A., ed. New York, Raven Press, 1978, pp M a n s o n -B a h r, P. E. C.: Immunity in kala-azar. Trans. Roy. Soc. Trop. M ed. Hyg. 55: , N acy, C. A.: M acrophage activation to kill Leishmania donovani: Characterization of a T cell-derived factor that suppresses lymphokineinduced intracellular destruction of amastigotes. J. Immunol. 233: , OSEBOLD, J. W.: M echanism s of action b y im m unologic adjuvants. J. Amer. Vet. Med. Assoc. 181: , Poulter, L. W.: M echanisms of im m unity to leishmaniasis: Evidence for a changing basis of protection in self-limiting disease. Clin. Exp. Immunol. 39:14-26, R e e d, S. G., Barral-N e t t o, M., and I n v e r so, J. A.: Treatment of experimental visceral leishmaniasis with lymphokine encapsulated in liposomes. J. Immunol. 232: , Re e s, P. H., Ka g e r, P. A., W e l l d e, B. T., and H ockm EYER, W. T.: The response of Kenyan kala-azar to treatm ent with sodium stibogluconate. Amer. J. Trop. Med. Hyd. 33: , Sarosa, J. A., Ba h r a w i, W., W it ja k s o n o, H., B u d ia r so, R. L. P., B r o to w a sisto B e n c ic, Z., D e W it t, W. E., and G o m e z, C. Z.: A controlled field trial of plain and alum inum hyodroxide-adsorbed cholera vaccines in Suraboya, Indonesia during B ull. W HO 56: , St ä u b e r, L. A.: Characterization of strains of Leishmania donovani. Exp. Parasit. 28:1-11, Stä u b er, L. A.: Leishmaniasis in the hamster. Some Physiological Aspects and Consequences of Parasitism. Cole, W. H., ed. New Brunswick, NJ, Rutgers University Press, 1955, pp St e c k, E. A. andklnnamon, K. E.: Leishmania donovani, Plasmodium berghei, Trypanosoma rhodesiense: Anti-protozoal effects of some amidine types. Exp. Parasit. 52: , 1981.
Antithymocyte Serum Suppression of Immunity in Mice Immunized to Leishmania donovani*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 20, No. 4 Copyright 1990, Institute for Clinical Science, Inc. Antithymocyte Serum Suppression of Immunity in Mice Immunized to Leishmania donovani* G.
More informationHAEMOFLAGELLATES. Dr. Anuluck Junkum Department of Parasitology Faculty of Medicine
HAEMOFLAGELLATES Dr. Anuluck Junkum Department of Parasitology Faculty of Medicine Objective Can describe the morphology, life cycle, pathology, diagnosis and prevention of Leishmania spp. and Trypanosoma
More informationLaboratory diagnosis of Blood and tissue flagellates
Laboratory diagnosis of Blood and tissue flagellates (Leishmania and trypanosma) Sarah Alharbi Clinical Laboratory department Collage of Applied Medical Sciences King Saud University Leishmania and trypanosma:
More informationBlood Smears Only 6 October Sample Preparation and Quality Control 15B-K
NEW YORK STATE Parasitology Proficiency Testing Program Blood Smears Only 6 October 5 The purpose of the New York State Proficiency Testing Program in the category of Parasitology - Blood Smears Only is
More information199 (M. A. Bioproducts, Walkersville, Md.). placed on 22-mm2 cover slips and incubated at 37 C in
INFECTION AND IMMUNITY, June 1981, p. 1249-1253 0019-9567/81/061249-05$02.00/0 Vol. 32, No. 3 Interaction of Leishmania donovani Promastigotes with Human Monocyte-Derived Macrophages: Parasite Entry, Intracellular
More informationBlood Smears Only 07 February Sample Preparation and Quality Control 12B A
NEW YORK STATE Parasitology Proficiency Testing Program Blood Smears Only 07 February 2012 The purpose of the New York State Proficiency Testing Program in the category of Parasitology Blood Smears Only
More informationPHENANTHRIDINE COMPOUNDS
Brit. J. Pharmacol. (195), 5, 398. THE CHEMOTHERAPEUTIC ACTION OF PHENANTHRIDINE COMPOUNDS PART IV ACTIVITY IN VITRO BY J. A. LOCK From the Wellcome Laboratories of Tropical Medicine, N.W.1 183, Euston
More informationVisceral leishmaniasis: an endemic disease with global impact
Visceral leishmaniasis: an endemic disease with global impact Professor Olivier Lortholary, MD, PhD Department of Infectious and Tropical diseases Hôpital Necker-Enfants Malades Université Paris Descartes
More informationLeishmaniasis, Kala Azar(The Black Fever)
Leishmaniasis, Kala Azar(The Black Fever) By Lawrence Hall Etiologic agent Protist obligate intracellular parasite, Transmission Vectors Phylum: Euglenozoa (genus Leishmania) Over 21 species that infect
More informationProtozoa from tissues. Leishmania spp. Naegleria fowleri Toxoplasma gondii Trichomonas vaginalis Trypanosoma spp.
Protozoa from tissues Leishmania spp. Naegleria fowleri Toxoplasma gondii Trichomonas vaginalis Trypanosoma spp. Leishmaniasis Leishmania infantum, Leishmania donovani, in macrophages of man. Female sandflies:
More informationEfficacies of Vesicular and Free Sodium Stibogluconate Formulations against Clinical Isolates of Leishmania donovani
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2001, p. 3555 3559 Vol. 45, No. 12 0066-4804/01/$04.00 0 DOI: 10.1128/AAC.45.12.3555 3559.2001 Copyright 2001, American Society for Microbiology. All Rights
More informationSTUDIES ON ISOMETAMIDIUM: THE EFFECT OF ISOMETAMIDIUM, HOMIDIUM AND PYRITHIDIUM ON THE INFECTIVITY OF TRYPANOSOMES FOR MICE
Brit. J. Pharmacol. (1965), 25, 658-663. STUDIES ON ISOMETAMIDIUM: THE EFFECT OF ISOMETAMIDIUM, HOMIDIUM AND PYRITHIDIUM ON THE INFECTIVITY OF TRYPANOSOMES FOR MICE BY J. HILL From the Research Laboratories,
More information~Trichinella Spiralis:
Musculoskeletal System **Today we are going to talk about the parasites that affect the musculoskeletal system ~Trichinella Spiralis: It s a small nematode that measures to about 2-3mm in length. In general
More informationSMe. Me NITROIMIDAZOLES FOR VISCERAL LEISHMANIASIS FEXINIDAZOLE AND VL-2098 SHYAM SUNDAR
SMe O 2 CH 2 O Me ITROIMIDAZOLES FOR VISCERAL LEISHMAIASIS FEXIIDAZOLE AD VL-2098 SHYAM SUDAR Target Product Profile for a CE Optimal Target Profile Target Label VL and PKDL VL Spp All species L. donavani
More informationThe Most Common Parasitic Infections In Yemen. Medical Parasitology
The Most Common Parasitic Infections In Yemen Medical Parasitology ﻓﺎﯾز اﻟﺧوﻻﻧﻲ / د 2 : is a vector-borne disease that transmitted by sandflies and caused by obligate intracellular protozoa of the genus
More informationPathophysiology of Experimental Leishmaniasis: Pattern of Development of Metastatic Disease in the Susceptible Host
INFCTION AND IMMUNITY, May 1986, p. 364-369 19-9567/86/5364-6$2./ Copyright 1986, American Society for Microbiology Vol. 52, No. 2 Pathophysiology of xperimental Leishmaniasis: Pattern of Development of
More informationE levated Prolactin Level in Prostates with Latent Carcinoma
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 3 Copyright 1987, Institute for Clinical Science, Inc. E levated Prolactin Level in Prostates with Latent Carcinoma RYUICHI YATANI, M.D.,* ITSUO
More informationMorphological forms of hemoflagellates
Parasitology Lecture: 1 Hemoflagellates (blood and tissue flagellates) *Classification: - Sub-kingdom: Protozoa -Phylum: Sarcomastigophora -Sub-phylum: Mastigiphora -Class: Zoomastigophora د. رائد *Flagellates
More informationMechanistic Studies of Pentamidine Analogs on Leishmania donovani Promastigotes
Mechanistic Studies of Pentamidine Analogs on Leishmania donovani Promastigotes Undergraduate Honors Thesis The Ohio State University, College of Pharmacy Division of Medicinal Chemistry and Pharmacognosy
More information2.Trichomonas vaginalis
2.Trichomonas vaginalis 1. Pathogenic to human &causes vaginitis (trichomoniasis). 2. troph. Is round or pear like in shape, contains 4-6 flagella, all originating from anterior end & only one extend posteriorly.
More informationPublic health, innovation, and Intellectual Property Rights EU input to the global debate
Public health, innovation, and Intellectual Property Rights EU input to the global debate Brussels, April 2, 2007 An Overview of Medical Needs Kees de Joncheere WHO/EURO 1 Leading Causes of Death 53.9
More informationBIO Parasitology Spring 2009
BIO 475 - Parasitology Spring 2009 Stephen M. Shuster Northern Arizona University http://www4.nau.edu/isopod Lecture 5 Discovery of the Disease In 1924 the Kala-Azar Commission noted that the distribution
More informationTreatment of Cutaneous Leishmaniasis with Allopurinol and Stibogluconate
165 Treatment of Cutaneous Leishmaniasis with Allopurinol and S. Martinez, M. Gonzalez, and M. E. Vernaza From the Department of Internal Medicine, University of Cauca, Popayan, and the University Hospital
More informationAnalysis of Enhancing Effect of Sand Fly Saliva on Leishmania Infection in Mice
INFCTION AND IMMUNITY, May 1991, p. 1592-1598 19-9567/91/51592-7$2./ Copyright X) 1991, American Society for Microbiology Vol. 59, No. 5 Analysis of nhancing ffect of Sand Fly Saliva on Leishmania Infection
More informationNanomedicine & Drug Delivery Systems Group Research Institute for Medicines and Pharmaceutical Sciences (imed.ul)
Faculty of Pharmacy of the University of Lisbon Nanomedicine & Drug Delivery Systems Group Research Institute for Medicines and Pharmaceutical Sciences (imed.ul) Leishmania in southern Europe. (Duiardin,
More informationControl of leishmaniasis
SIXTIETH WORLD HEALTH ASSEMBLY A60/10 Provisional agenda item 12.3 22 March 2007 Control of leishmaniasis Report by the Secretariat BACKGROUND 1. Leishmaniasis is endemic in 88 countries in the world and
More informationImmunomodulation of Visceral leishmaniasis with Peganum harmala Seeds Extract in experimental Animals
Immunomodulation THE IRAQI POSTEGRADUATE of Visceral leishmaniasis MEDICAL JOURNAL Wassan A. Al-Saidi, etal. Immunomodulation of Visceral leishmaniasis with Peganum harmala Seeds Extract in experimental
More informationHLA Alloimmunization with Leukocyte Concentrates from HLA-matched and HLA-non-m atched Donors in Patients with H unter s Syndrom e*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 15, No. 5 Copyright 1985, Institute for Clinical Science, Inc. HLA Alloimmunization with Leukocyte Concentrates from HLA-matched and HLA-non-m atched Donors
More informationElimination of VL in the Indian subcontinent is it achievable?
Elimination of VL in the Indian subcontinent is it achievable? P Das Rajendra Memorial Research Institute, Patna Jorge Alvar DNDi, Geneva Bhawna Sharma DNDi, India Leishmaniasis 350 million at risk worldwide
More informationLeishmaniasis: Challenges for Vaccine Development
Leishmaniasis: Challenges for Vaccine Development Steven G. Reed Infectious Disease Research Institute Seattle IDRI Goals: Leishmaniasis To improve existing vaccines for use in therapy and prevention.
More informationSensitivity of Serum Fructosamine in Short Term Glycemic Control
A N N A L S O F C L IN IC A L A N D L A B O R A T O R Y S C IE N C E, Vol. 19, N o. 2 Copyright 1989, Institute for Clinical Science, Inc. Sensitivity of Serum Fructosamine in Short Term Glycemic Control
More informationEXPERIMENTAL SALMONELLOSIS
EXPERIMENTAL SALMONELLOSIS INTRACELLULAR GROWTH OF Salmonella enteritidis INGESTED IN MONONUCLEAR PHAGOCYTES OF MICE, AND CELLULAR BASIS OF IMMUNITY SUSUMU MITSUHASHI, ICHIEI SATO, AND TOKUMITSU TANAKA
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTRY INFORMTION doi:10.1038/nature11808 NT Phen Met ICR Oligo FCCP pmpk tmpk Supplemental figure 1. -. Primary hepatocytes were treated with 250 um Phenformin, 1 mm Metformin 250 um ICR, 100 nm
More informationEastern Mediterranean Health Journal, Vol. 9, No. 4,
Eastern Mediterranean Health Journal, Vol. 9, No. 4, 2003 837 Antimony-resistant Leishmania donovani in eastern Sudan: incidence and in vitro correlation M.G. Abdo, 1 W.M. Elamin, 1 E.A.G. Khalil 1 and
More informationWelcome to the Jungle! Dr Aileen Oon, 2017 Microbiology Registrar
Welcome to the Jungle! Dr Aileen Oon, 2017 Microbiology Registrar AA 55M presented with sores on left olecranon and umbilical area Umbilical sores present for 3 weeks Left olecranon lesions for 1 week
More informationActa Dermatovenerol Croat 2008;16(2):60-64 CLINICAL ARTICLE
2008;16(2):60-64 CLINICAL ARTICLE Clinical Efficacy of Intramuscular Meglumine Antimoniate Alone and in Combination with Intralesional Meglumine Antimoniate in the Treatment of Old World Cutaneous Leishmaniasis
More informationResolution of an Infection with Leishmania braziliensis Confers Complete Protection to a Subsequent Challenge with Leishmania major in BALB/c Mice
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 94(1): 71-76, Jan./Feb. 1999 Resolution of an Infection with Leishmania braziliensis Confers Complete Protection to a Subsequent Challenge with Leishmania major
More informationNanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an in vitro and in vivo study
DARU Vol. 17, No. 4 2009 285 Nanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an in vitro and in vivo study *1 Mohebali M., 2 Rezayat M.M., 3
More informationLeishmaniasis vaccine development: Animals as models and patients
Engineering Conferences International ECI Digital Archives Vaccine Technology IV Proceedings Spring 5-22-2012 Leishmaniasis vaccine development: Animals as models and patients Steven Reid IDRI Follow this
More informationGamma-aminobutyric acid (GABA) treatment blocks inflammatory pathways and promotes survival and proliferation of pancreatic beta cells
Gamma-aminobutyric acid (GABA) treatment blocks inflammatory pathways and promotes survival and proliferation of pancreatic beta cells Gérald J. Prud homme, MD, FRCPC Keenan Research Centre for Biomedical
More informationSeries Editors Samuel J. Black, University of Massachusetts, Amherst, MA, US.A. J. Richard Seed, University of North Carolina, Chapel Hill, NC, US.A.
LEISHMANIA World Class Parasites VOLUME 4 Volumes in the World Class Parasites book series are written for researchers, students and scholars who enjoy reading about excellent research on problems of global
More informationNecrotizing and suppurative lymphadenitis in Leishmania
Tropical Medicine and International Health VOLUME I NO. 2 PP 243-250 APRIL 1996 Necrotizing and suppurative lymphadenitis in Leishmania major infections A. Gaafar r, A. Ismai13, A. Y. El Kadaro4, Elsir
More informationWhat is Kala-azar? What are Signs & Symptoms of Kala-Azar?
What is Kala-azar? Kala-azar is a slow progressing indigenous disease caused by a protozoan parasite of genus Leishmania In India Leishmania donovani is the only parasite causing this disease The parasite
More informationLeishmaniasis: Current Status of Vaccine Development
CLINICAL MICROBIOLOGY REVIEWS, Apr. 2001, p. 229 243 Vol. 14, No. 2 0893-8512/01/$04.00 0 DOI: 10.1128/CMR.14.2.229 243.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Leishmaniasis:
More informationHOST RESISTANCE TO THE KHARTOUM STRAIN OF LEISHMANIA DONOVAN1
HOST RESISTANCE TO THE KHARTOUM STRAIN OF LEISHMANIA DONOVAN1 LESLIE A. STAUBER Bzcreazc of BioZogical Research, Rutgers, The State University, New Bn~nswick, New Jersey C OMPARED with trypanosomiasis
More informationAnimal models for infectious diseases caused by parasites: Leishmaniasis
Drug Discovery Today: Disease Models Vol. 1, No. 1 2004 DRUG DISCOVERY TODAY DISEASE MODELS Editors-in-Chief Jan Tornell AstraZeneca, Sweden Denis Noble University of Oxford, UK Infectious diseases Animal
More informationIranian J Parasitol: Vol. 8, No.3, July -Sep 2013, pp Iranian J Parasitol. Open access Journal at ijpa.tums.ac.ir
Iranian J Parasitol: Vol. 8, No.3, July -Sep 2013, pp.396-401 Iranian J Parasitol Tehran University of Medical Sciences Publication http:// tums.ac.ir Open access Journal at http:// ijpa.tums.ac.ir Iranian
More informationPersonalized Cancer Neoantigen Vaccines
Personalized Cancer Neoantigen Vaccines Turning the Immune System Against Your own Unique Tumour-Specific Antigens 3 rd Annual Advances in Immuno-Oncology Congress London, May 24, 2018 Agnete Fredriksen,
More informationLeishmaniasis. By Joseph Knight, PA-C. 2. Explain the differences in the reasons leishmaniasis is spreading in Afghanistan and India.
Leishmaniasis By Joseph Knight, PA-C Objectives 1. Identify the two types of leishmaniasis. 2. Explain the differences in the reasons leishmaniasis is spreading in Afghanistan and India. 3. Discuss how
More informationTOWARD AN APPROACH FOR CUTANEOUS LEISHMANIA TREATMENT. Mohammed Wael Daboul
Original Articles DOI: 10.7241/ourd.20131.09 Source of Support: Nil Competing Interests: None TOWARD AN APPROACH FOR CUTANEOUS LEISHMANIA TREATMENT Mohammed Wael Daboul Laboratory Medicine Specialist,
More informationC for 2 hr at 22,620 X G. The supernatant fluid. was discarded and the sediment resuspended to
SAFETY TEST FOR Q FEVER VACCINE SANFORD BERMAN, GERALD LE, JOSEPH P. LOWENTHAL, AND RAYMOND B. GOCHENOUR Department of Biologics Research, Division of Immunology, Walter Reed Army Institute of Research,
More informationLeishmaniasis: A forgotten disease among neglected people
ISPUB.COM The Internet Journal of Health Volume 11 Number 2 Leishmaniasis: A forgotten disease among neglected people Y Homsi, G Makdisi Citation Y Homsi, G Makdisi. Leishmaniasis: A forgotten disease
More informationAntimonial Resistance & Combination therapy in Indian Visceral Leishmaniasis. Shyam Sundar Banaras Hindu University Varanasi, India
Antimonial Resistance & Combination therapy in Indian Visceral Leishmaniasis Shyam Sundar Banaras Hindu University Varanasi, India History of the Current Epidemic in India & Antimony Resistance 6 Official
More informationLeishmaniasis. CDR R.L. Gutierrez Oct 2014
Leishmaniasis CDR R.L. Gutierrez Oct 2014 Overview Protozoan parasite(s) of tissue and WBCs Many species / Many Syndromes (Cutaneous / Visceral) Pathogen: Location - Old World vs. New World Host: Immune
More informationDesign and Antileishmanial Activity of Amphotericin B-Loaded Stable Ionic Amphiphile Biovector Formulations
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2002, p. 1597 1601 Vol. 46, No. 5 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.5.1597 1601.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationCell-Mediated Immune Response in Indian Kala Azar and
INFECTION AND IMMUNITY, Nov. 1983, p. 702-707 Vol. 42, No. 2 0019-9567/83/110702-06$02.00/0 Copyright 1983, American Society for Microbiology Cell-Mediated Immune Response in Indian Kala Azar and Post-Kala
More informationScreening Hospitalized Injured Drivers and Other Trauma Victims for Alcoholism Using Two Questions
Screening Hospitalized Injured Drivers and Other Trauma Victims for Alcoholism Using Two Questions C arl A. S o d e r str o m, M.D.,1 P a tricia C. D isc h in g e r, P h.d.,2 G ord on S. S m ith, M.D.3
More informationAnimal Models of Leishmaniasis Relevant to Vaccine Development. David Sacks Laboratory of Parasitic Diseases NIAID, NIH
Animal Models of Leishmaniasis Relevant to Vaccine Development David Sacks Laboratory of Parasitic Diseases NIAID, NIH Leishmaniasis: A spectrum of diseases associated with a diversity of parasite species,
More informationSodium Stibogluconate treatment for cutaneous leishmaniasis: A clinical study of 43 cases from the north of Jordan
Sodium Stibogluconate treatment for cutaneous leishmaniasis: A clinical study of 43 cases from the north of Jordan Mamoun Mohammad Al-Athamneh Hiathem Qasem Abu Al-haija Ra ed Smadi Ayman S. Qaqaa Heba
More informationHexadecylphosphocholine: Oral Treatment of Visceral Leishmaniasis in Mice
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1992, p. 1630-1634 Vol. 36, No. 8 0066-4804/92/081630-05$02.00/0 Hexadecylphosphocholine: Oral Treatment of Visceral Leishmaniasis in Mice ARMIN KUHLENCORD,1*
More informationby author Drug Therapy in African Visceral Leishmaniasis 28th ECCMID Conference, Madrid, Spain 21 April 2018
Drug Therapy in African Visceral Leishmaniasis 28th ECCMID Conference, Madrid, Spain 21 April 2018 Dr. Monique Wasunna, Director, DNDi Africa Regional Office Presentation Outline 1 2 4 5 Introduction leishmaniasis
More informationEfficacies of KY62 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous Leishmaniasis and Visceral Leishmaniasis
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1998, p. 2542 2548 Vol. 42, No. 10 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Efficacies of KY62 against Leishmania
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007 Hosted by: Australian Small Animal Veterinary Association (ASAVA) Australian Small Animal Veterinary Association (ASAVA)
More informationSingle-Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study
MAJOR ARTICLE Single-Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study S. Sundar, 1 T. K. Jha, 2 C. P. Thakur, 3 M. Mishra, 4 V. P. Singh, 1 and R.
More informationVaccinology 101 for Fellows
Vaccinology 101 for Fellows Meg Fisher, MD Medical Director, The Children s Hospital Monmouth Medical Center An affiliate of the Saint Barnabas Health Care System Long Branch, NJ Disclosures I have no
More informationProgestin-only methods Type or dose of progestagen
Progestin-only contraception and beneficial effects on migraine Conflicts of interest A d v ise r a n d le ctu re r fo r E X E LT IS Le ctu re s a n d A d v iso ry b o a rd s B aye r Le ctu re s a n d
More informationLeishmaniasis. MAJ Kris Paolino September 2014
Leishmaniasis MAJ Kris Paolino September 2014 Thanks to COL (Ret) Kent Kester MAJ Leyi Lin http://www.niaid.nih.gov/topics/leishmaniasis History Sir William Boog Leishman (1865-1926) Matriculated at the
More informationPolicy and technical topics: Selected neglected tropical diseases targeted for elimination: kala-azar, leprosy, yaws, filariasis and schistosomiasis
REGIONAL COMMITTEE Provisional Agenda item 8.3 Sixty-eighth Session SEA/RC68/12 Dili, Timor-Leste 7 11 September 2015 21 July 2015 Policy and technical topics: Selected neglected tropical diseases targeted
More informationTHE EFFECTS OF ACIDITY UPON THE GROWTH OF PNEUMOCOCCUS IN CULTURE MEDIA CONTAINING PROTEINS
THE EFFECTS OF ACIDITY UPON THE GROWTH OF PNEUMOCOCCUS IN CULTURE MEDIA CONTAINING PROTEINS BY WILLIAM H. KELLEY, M.D. (From the Department of Medicine of the Duke University School of Medicine, Durham,
More informationBlocking antibodies and peptides. Rat anti-mouse PD-1 (29F.1A12, rat IgG2a, k), PD-
Supplementary Methods Blocking antibodies and peptides. Rat anti-mouse PD-1 (29F.1A12, rat IgG2a, k), PD- L1 (10F.9G2, rat IgG2b, k), and PD-L2 (3.2, mouse IgG1) have been described (24). Anti-CTLA-4 (clone
More informationSupporting Information. Maximizing the Supported Bilayer Phenomenon: LCP Liposomes Comprised Exclusively
S-1 Supporting Information Maximizing the Supported Bilayer Phenomenon: LCP Liposomes Comprised Exclusively of PEGylated Phospholipids for Enhanced Systemic and Lymphatic Delivery Matthew T. Haynes and
More informationDENDRITIC CELLS ACTIVATED BY CpG MOTIFS ARE POTENT INDUCERS OF A TH1 IMMUNE RESPONSE THAT PROTECTS MICE AGAINST LEISHMANIASIS
DENDRITIC CELLS ACTIVATED BY CpG MOTIFS ARE POTENT INDUCERS OF A TH1 IMMUNE RESPONSE THAT PROTECTS MICE AGAINST LEISHMANIASIS Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen
More informationReceived: 11 th August-2012 Revised: 14 th Sept-2012 Accepted: 16 th Sept-2012 Research article
Received: 11 th August-2012 Revised: 14 th Sept-2012 Accepted: 16 th Sept-2012 Research article IN VITRO ANTILEISHMANIAL ACTIVITY OF NYCTANTHES ARBOR-TRISTIS A MEDICINAL TREE Dr. Assistant Professor, Department
More informationExperiment #1 TARGET Mouse Model Group. Report prepared by Paul Converse, Ph.D. and Eric Nuermberger, M.D. March 1, 2006
Protocol for in vivo evaluation of growth rates and pathogenesis of M. tuberculosis strains found to have rapid or slow growth phenotypes in an in vitro model Experiment #1 TARGET Mouse Model Group Report
More informationEosinophils and Mast Cells in Leishmaniasis
Available online at www.scholarsresearchlibrary.com Annals of Biological Research, 211, 2 (6) :36-41 (http://scholarsresearchlibrary.com/archive.html) ISSN 976-1233 CODEN (USA): ABRNBW Eosinophils and
More informationLeishmania major Infection
Immunotherapy with Imiquimod Increases the Efficacy of Glucantime Therapy of Leishmania major Infection Ghader Khalili 1, Faramarz Dobakhti 2, Hamid Mahmoudzadeh Niknam 1, Vahid Khaze 1, Fatemeh Partovi
More informationIMMUNIZATION OF MICE AND GUINEA-PIGS AGAINST SALMONRLLA DUBLIN INFECTION WITH LIVE AND INACTIVATED VACCINE
Onderstepoort. vet. Res. 42 (2), 63-70 (1975) IMMUNIZATION OF MICE AND GUINEA-PIGS AGAINST SALMONRLLA DUBLIN INFECTION WITH LIVE AND INACTIVATED VACCINE C. M. CAMERON and W.. P. FULS, Veterinary Research
More informationCELL MEDIATED IMMUNE RESPONSE
CELL MEDIATED IMMUNE RESPONSE Chapter IV - CELL MEDIATED IMMUNE RESPONSE Sujatha, M. 2013. Evaluation of Immunological changes in Fish, Catla catla administered with bacterial pathogen, Aeromonas hydrophila,
More informationImmunologically Induced and Elicited Local
INFECTION AND IMMUNITY, Dec. 1970, p. 757-761 Copyright 1970 American Society for Microbiology Vol. 2, No. 6 Printed in U.S.A. Immunologically Induced and Elicited Local Resistance to Staphylococcus aureus
More informationImproved Immunodiagnosis of Neutrophil Dysfunction in the Newborn and Infant
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 12, No. 2 Copyright 1982, Institute for Clinical Science, Inc. Improved Immunodiagnosis of Neutrophil Dysfunction in the Newborn and Infant ALAN B. LOREN,
More informationTherapeutic Options for Visceral Leishmaniasis
Drugs (2013) 73:1863 1888 DOI 10.1007/s40265-013-0133-0 REVIEW ARTICLE Therapeutic Options for Visceral Leishmaniasis Begoña Monge-Maillo Rogelio López-Vélez Published online: 30 October 2013 Ó The Author(s)
More informationA Supplement to Alkaline Phosphatase Fractionations: Utilization of Gamma- Glutamyl Transpeptidase and Hydroxyproline Assays
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 8, No. 2 Copyright 1978, Institute for Clinical Science A Supplement to Alkaline Phosphatase Fractionations: Utilization of Gamma- Glutamyl Transpeptidase
More informationEpidemiological, clinical & pharmacological study of antimonyresistant visceral leishmaniasis in Bihar, India
Indian J Med Res 120, September 2004, pp 166-172 Epidemiological, clinical & pharmacological study of antimonyresistant visceral leishmaniasis in Bihar, India C.P. Thakur, S. Narayan* & A. Ranjan* Balaji
More informationPost Kala-azar Dermal Leishmaniasis (PKDL) from the field to the cellular and the subcellular levels
Post Kala-azar Dermal Leishmaniasis (PKDL) from the field to the cellular and the subcellular levels A M EL Hassan Institute of Endemic Diseases University of Khartoum Introduction PKDL is a VL related
More informationAperito Journal of Bacteriology, Virology and Parasitology. Therapeutic Potential of Nanoparticulate System for Treatment. of Protozoan Infection
Aperito Journal of Bacteriology, Virology and Parasitology Received: Sep 19, 2014 Accepted: Oct 08, 2014 Published: Oct 12, 2014 http://dx.doi.org/10.14437/ajbvp-1-102 Editorial Arghya Bandyopadhyay, Aperito
More informationTrends in vaccinology
Trends in vaccinology Mathieu Peeters, MD Joint Conference of European Human Pharmacological Societies and Joint Conference of European Human Pharmacological Societies and 20th Anniversary of AGAH March
More informationShort-Course Paromomycin Treatment of Visceral Leishmaniasis in India: 14-Day vs 21-Day Treatment
MAJOR ARTICLE Short-Course Paromomycin Treatment of Visceral Leishmaniasis in India: 14-Day vs 21-Day Treatment Shyam Sundar, Neha Agrawal, Rakesh Arora, Dipti Agarwal, Madhukar Rai, and Jaya Chakravarty
More informationEvolution of Virulence: Malaria, a Case Study Prof. Andrew F. Read
- - Evolution of Virulence: Evolution of Virulence: Andrew F. Read The University of Edinburgh Institutes of Evolutionary Biology & Immunology and Infection Research http://readgroup.biology.ed.ac.uk/
More informationM.Sc. III Semester Biotechnology End Semester Examination, 2013 Model Answer LBTM: 302 Advanced Immunology
Code : AS-2246 M.Sc. III Semester Biotechnology End Semester Examination, 2013 Model Answer LBTM: 302 Advanced Immunology A. Select one correct option for each of the following questions:- 2X10=10 1. (b)
More informationLopes R, Carvalheiro M, Eleutério CV, Corvo ML, Almeida AJ, Cruz MEM
Lopes R, Carvalheiro M, Eleutério CV, Corvo ML, Almeida AJ, Cruz MEM imed.ul- Research Institute for Medicines and Pharmaceutical Sciences, Faculdade de Farmácia, Universidade Lisboa Workshop Antiparasitic
More information(From the Department of Animal and Plant Pathology of The Rockefeller Institute for Medical Research, Princeton, New Jersey)
THE YIELD OF RABIES VIRUS IN THE CHICK EMBRYO BY BJORN SIGURDSSON, M.D.* (From the Department of Animal and Plant Pathology of The Rockefeller Institute for Medical Research, Princeton, New Jersey) (Received
More informationMalaria parasite vaccine development Strategies & Targets
Malaria parasite vaccine development Strategies & Targets Tulane University Ahmed Aly Most malaria disease deaths are among children and pregnant women A child or a pregnant woman dies of malaria nearly
More informationTherapeutic Effect of Clindamycin and Tetracycline on Babesia rodhaini Infection in Mouse Model
FULL PAPER Parasitology Therapeutic Effect of Clindamycin and Tetracycline on Babesia rodhaini Infection in Mouse Model Agus WIJAYA, Retno WULANSARI, Hitoshi ANO, Hisashi INOKUMA 1) and Susumu MAKIMURA
More informationSupplementary figure 1. Systemic delivery of anti-cd47 antibody controls tumor growth in
T u m o r v o lu m e (m m 3 ) P e rc e n t s u rv iv a l P e rc e n t s u rv iv a l Supplementary data a 1 8 6 4 2 5 1 1 5 2 2 5 3 3 5 4 T im e a fte r tu m o r in o c u la tio n (d ) b c 1 5 1 1 5 * *
More informationLD 60 determinations.-in order to study the resistance of mice to H. RESISTANCE INDUCED AGAINST HISTOPLASMA CAPSULA TUM: QUANTITATIVE ASPECTS*
RESISTANCE INDUCED AGAINST HISTOPLASMA CAPSULA TUM: QUANTITATIVE ASPECTS* GILBERT A. HILLt AND STANLEY MARCUS From the Department of Bacteriology, College of Medicine, University of Utah, Salt Lake City
More informationWMLN Case Study. Necrotizing Palate Biopsy Specimen. Youngmi Kim Sr. Microbiologist TB Lab & Parasitology Lab MS, M(ASCP)
WMLN Case Study Necrotizing Palate Biopsy Specimen Youngmi Kim Sr. Microbiologist TB Lab & Parasitology Lab MS, M(ASCP) 44 year old male from Honduras Immigrated to US 12 years ago to WI 4 years ago Seen
More informationLaboratory investigation of Cutaneous Leishmaniasis in Karachi
Laboratory investigation of Cutaneous Leishmaniasis in Karachi Pages with reference to book, From 248 To 250 G.M. Rajpar, M.A. Khan, A. Hafiz ( Department of Microbiology, Jinnah Postgraduate Medical Centre,
More informationEffect of Vaccine, Route, and Schedule on Antibody
APPUED MICROBIOLOGY, Mar. 1969, p. 355-359 Copyright 1969 American Society for Microbiology Vol. 17, No. 3 Printed in U.S.A. Effect of Vaccine, Route, and Schedule on Antibody Response of Rabbits to Pasteurella
More information[3]... [2]... [1]
1 Malaria is a disease that is estimated to kill around 80 people every hour worldwide. (a) The symptoms of malaria are caused by a single-celled organism belonging to the genus Plasmodium. (i) Plasmodium
More informationControl of leishmaniasis
EXECUTIVE BOARD EB118/4 118th Session 11 May 2006 Provisional agenda item 5.1 Control of leishmaniasis Report by the Secretariat BACKGROUND 1. Leishmaniasis is endemic in 88 countries in the world and
More information